$TRAW 4 SEC Filings

Filed On	Filing
16 Jul 2026	Form 4: Pauza Charles David, Chief Science Officer Virology Granted 97,000 Stock Option (right to buy)
15 Jul 2026	Form 4: Savchuk Nikolay, Director Granted 93,000 Stock Option (right to buy)
15 Jul 2026	Form 4: Cautreels Werner, Director Granted 14,150 Stock Option (right to buy)
14 Jul 2026	Form 4: Dukes Iain D., Director Granted 274,000 Stock Option (right to buy)
14 Jul 2026	Form 4: Redfield Robert, Chief Medical Officer Granted 84,000 Stock Option (right to buy)
14 Jul 2026	Form 4: Parker Charles Nolan, Chief Financial Officer Granted 90,000 Stock Option (right to buy)
14 Jul 2026	Form 4: Shoemaker Mary Teresa, Director Granted 14,150 Stock Option (right to buy)
14 Jul 2026	Form 4: Clarke Trafford, Director Granted 14,150 Stock Option (right to buy)
14 Jul 2026	Form 4: Leaman John Harold, Director Granted 14,150 Stock Option (right to buy)
14 Jul 2026	Form 4: Stover Jack E, Director Granted 14,150 Stock Option (right to buy)
28 Apr 2026	Form 4: Orbimed Advisors Llc, 10% owner and 1 other Bought 597,729 shares ($998K) · Acquired 597,729 Series A Warrants (right to buy) (Open Market Purchase) · Acquired 597,729 Series B Warrants (right to buy) (Open Market Purchase) · 1 more
08 Apr 2026	Form 4: Parker Charles Nolan, Chief Financial Officer Granted 32,406 Stock Option (right to buy) · Received 15,393 shares as a grant or award · Granted 61,571 Stock Option (right to buy) · 1 more
10 Mar 2026	Form 4: Clarke Trafford, Director Granted 33,435 Stock Option (right to buy)
10 Mar 2026	Form 4: Cautreels Werner, Director Granted 31,258 Stock Option (right to buy)
10 Mar 2026	Form 4: Leaman John Harold, Director Granted 33,435 Stock Option (right to buy)
10 Mar 2026	Form 4: Dukes Iain D., Director Granted 231,336 Stock Option (right to buy)
10 Mar 2026	Form 4: Pauza Charles David, Chief Science Officer Virology Granted 118,367 Stock Option (right to buy)
10 Mar 2026	Form 4: Savchuk Nikolay, Director Granted 96,899 Stock Option (right to buy)
10 Mar 2026	Form 4: Stover Jack E, Director Granted 33,435 Stock Option (right to buy)
10 Mar 2026	Form 4: Redfield Robert, Chief Medical Officer Granted 108,854 Stock Option (right to buy)

Comments